Literature DB >> 2381939

The use of N-ethyl-N-nitrosourea to produce mouse models for human phenylketonuria and hyperphenylalaninemia.

J D McDonald1, V C Bode, W F Dove, A Shedlovsky.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2381939

Source DB:  PubMed          Journal:  Prog Clin Biol Res        ISSN： 0361-7742


× No keyword cloud information.
  5 in total

1.  Clinical therapeutics for phenylketonuria.

Authors:  Jaspreet Singh Kochhar; Sui Yung Chan; Pei Shi Ong; Lifeng Kang
Journal:  Drug Deliv Transl Res       Date:  2012-08       Impact factor: 4.617

Review 2.  Phenylketonuria as a model for protein misfolding diseases and for the development of next generation orphan drugs for patients with inborn errors of metabolism.

Authors:  Ania C Muntau; Søren W Gersting
Journal:  J Inherit Metab Dis       Date:  2010-09-08       Impact factor: 4.982

Review 3.  Gene Therapy for the Treatment of Neurological Disorders: Metabolic Disorders.

Authors:  Dominic J Gessler; Guangping Gao
Journal:  Methods Mol Biol       Date:  2016

4.  Forward genetic screens to identify circadian rhythm mutants in mice.

Authors:  Sandra M Siepka; Joseph S Takahashi
Journal:  Methods Enzymol       Date:  2005       Impact factor: 1.600

Review 5.  Therapeutic applications of gene editing in chronic liver diseases: an update.

Authors:  Ji Hyun Shin; Jinho Lee; Yun Kyung Jung; Kyeong Sik Kim; Jaemin Jeong; Dongho Choi
Journal:  BMB Rep       Date:  2022-06       Impact factor: 5.041
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.